Randomized, Placebo-Controlled Six-Month Intervention Study of Soy Protein Isolate in Men with Biochemical Recurrence after Radical Prostatectomy: A Pilot Study.

There is evidence to suggest that soy may be beneficial for prostate cancer patients, but few randomized trials have addressed this. We examined the effect of 6–8 mo soy protein supplementation on prostate specific antigen (PSA) serum levels in men who recurred (PSA > 0.1 ng/ml) within three years o...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Cancer Vol. 74; no. 2; pp. 555 - 565
Autores principales: Bosland, Maarten C., Schmoll, Joanne, Watanabe, Hiroko, Randolph, Carla, Kato, Ikuko
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Taylor & Francis Ltd 2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155436630&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 155436630
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: 2022
      vid: 74
      iid: 2
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        155436630
        149464547
        155436630
        155436630
        10.1080/01635581.2021.1903949
        155436630
      ppf: 555
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Randomized, Placebo-Controlled Six-Month Intervention Study of Soy Protein Isolate in Men with Biochemical Recurrence after Radical Prostatectomy: A Pilot Study.
      aug:
        au:
          Bosland, Maarten C.
          Schmoll, Joanne
          Watanabe, Hiroko
          Randolph, Carla
          Kato, Ikuko
        affil: Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA
      sug:
        subj:
          Soy Proteins Therapeutic Use
          Dietary Supplementation
          Neoplasm Recurrence, Local Prevention and Control
          Prostatic Neoplasms Surgery
          Prostatectomy, Radical
          Prostate-Specific Antigen Blood
          Treatment Outcomes Evaluation
          Human
          Randomized Controlled Trials
          Pilot Studies
          Placebos Administration and Dosage
          Male
          Random Assignment
          Genistein Administration and Dosage
          Isoflavones Administration and Dosage
          Caseins Administration and Dosage
          Pretest-Posttest Design
          Genistein Blood
          Cholesterol Blood
          Comparative Studies
          Middle Age
          Aged
          Soy Proteins Administration and Dosage
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
      ab: There is evidence to suggest that soy may be beneficial for prostate cancer patients, but few randomized trials have addressed this. We examined the effect of 6–8 mo soy protein supplementation on prostate specific antigen (PSA) serum levels in men who recurred (PSA > 0.1 ng/ml) within three years of prostatectomy. Sixteen men were randomized to 20 g soy protein (∼24–26/day genistein; ∼40–43/day total isoflavones) or casein placebo. PSA was measured at base line and at 1, 2, 4, and 6–8 mo. Serum genistein levels greatly increased from baseline and cholesterol decreased in the soy group. In both treatment arms PSA increased similarly and PSA doubling times were not different over the 6–8 mo study duration. Two subjects in each group had stable PSA. A literature search for clinical studies of soy, isoflavones, and PSA revealed that supplementation with soy or isoflavones did not affect PSA in virtually all clinical studies identified. Although this study is too small to draw a definitive conclusion on the effect of soy protein on PSA in men with biochemical failure, the null finding in this study is consistent with the results of virtually all reports of soy and soy isoflavones in the literature.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N